Table 6

Characteristics of the study sample of patients with and without LVH
LVH P values
Patient Group with LVH Patient group without LVH
Age (years) 56.8 ± 12.1 66.3 ± 10.6 0.001
Sex (male/female) 49/31 78/42 0.589
Family history of hypertension (yes/no) 48/32 65/55 0.415
Family history of stroke (yes/no) 15/65 24/96 0.827
Smokers (yes/ex/no) 17/18/45 18/24/78 0.404
Diabetes (yes/no) 2/78 18/102 0.004
Diastolic BP (mmHg) 73.8 ± 12.1 76.8 ± 11.8 0.094
Systolic BP (mmHg) 126.1 ± 25.3 137.9 ± 19.4 0.001
Pulse pressure (mmHg) 52.3 ± 18.0 61.1 ± 16.8 0.001
Fasting blood glucose (mmHg) 99.8 ± 23.6 104.7 ± 24.3 0.161
Total Cholesterol (mg/dl) 191.0 ± 38.6 182.3 ± 41.7 0.132
BMI (kg/m2) 27.2 ± 4.3 28.0 ± 4.8 0.235
Beta-blockers (yes/no) 31/49 36/84 0.199
Alphabeta-blockers (yes/no) 7/73 14/106 0.510
Alpha-blockers (yes/no) 5/75 11/109 0.456
Diuretics (yes/no) 25/55 62/58 0.004
ACE inhibitor (yes/no) 25/55 50/70 0.136
Dihydropyridine (yes/no) 17/63 35/85 0.211
eGFR (mL/min/1.73 m2) 79.9 ± 17.9 75.1 ± 19.5 0.071
Kidney Involvement (1/2 /3) 24/44/12 24/75/21 0.268
IMT (mm) 1.82 ± 0.93 2.52 ± 1.82 <0.001
Vascular abnormalities (no/ thickening/plaque) 20/11/49 6/11/103 <0.001
LVMi g/m2 105.0 ± 13.8 147.5 ± 27.3 <0.001

Data are expressed as mean and standard deviation for continuous variables (i.e. age) and as number of patients per each group for categorical variable (i.e. gender).

The p-values refer to t-test for continuous variables and χ2 for categorical variables.

Melillo et al.

Melillo et al. BMC Cardiovascular Disorders 2012 12:105   doi:10.1186/1471-2261-12-105

Open Data